MetalloBio's mission is fundamentally to change the nature of antibiotics and the treatment of infections.
In November this year, MetalloBio’s CEO, Dr. Michael Murray, will be presenting at the LSX Investival in London. He will take part in the Company Showcase session at 12:40 PM, introducing MetalloBio to an audience of investors and industry leaders. His presentation will share MetalloBio’s journey and vision, showcasing how the company is driving innovation to make a real impact in life sciences.